AC
GRNAW

Aristeia Capital’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Aristeia Capital’s Portfolio GRNAW Stock Details GRNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-47,709
Closed -$11K – 718
2022
Q2 		$11K Sell
47,709
-138,201
-74% -$111K ﹤0.01% 670
2022
Q1 		$144K Sell
185,910
-365,731
-66% -$268K ﹤0.01% 491
2021
Q4 		$656K Sell
551,641
-7,620
-1% -$8.69K 0.01% 423
2021
Q3 		$570K Buy
559,261
+236,803
+73% +$248K 0.01% 385
2021
Q2 		$348K Buy
+322,458
New +$285K 0.01% 417

Other funds holding GRNAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM

Aristeia Capital's GRNAW Position: Q3 2022 in Review

Aristeia Capital sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2022, closing a stake of 47,709 shares — an estimated $11K sold.

Aristeia Capital first reported a position in GRNAW in Q2 2021 and held it in 5 quarters. The position peaked at $656K in Q4 2021. 19 funds tracked by Wall St. Rank hold GRNAW as of Q3 2022.

  • Aristeia Capital reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2022 after selling out during the quarter.
  • Aristeia Capital sold 47,709 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2022, an estimated $11K.
  • Aristeia Capital first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q2 2021 and held it in 5 quarters.
  • Aristeia Capital's GreenLight Biosciences Holdings, PBC Warrant position peaked at $656K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2022.

Based on Aristeia Capital's 13F filing for Q3 2022, filed 14 Nov 2022.